{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:08:32Z","timestamp":1783944512675,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10620-019-05746-9","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T05:15:50Z","timestamp":1564463750000},"page":"2385-2394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment"],"prefix":"10.1007","volume":"64","author":[{"given":"Kazuichi","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"5746_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/BF02285209","volume":"40","author":"K Yoshida","year":"1995","unstructured":"Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561\u20131568. \n                    https:\/\/doi.org\/10.1007\/bf02285209\n                    \n                  .","journal-title":"Dig Dis Sci"},{"key":"5746_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352\u2013358.","journal-title":"Pancreas"},{"key":"5746_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1\u201314.","journal-title":"Mod Rheumatol"},{"key":"5746_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/BF02232341","volume":"6","author":"H Sarles","year":"1961","unstructured":"Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas\u2014an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688\u2013698.","journal-title":"Am J Dig Dis"},{"key":"5746_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.7326\/0003-4819-66-5-884","volume":"66","author":"DE Comings","year":"1967","unstructured":"Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Ann Intern Med. 1967;66:884\u2013892.","journal-title":"Ann Intern Med"},{"key":"5746_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01072494","volume":"23","author":"S Nakano","year":"1978","unstructured":"Nakano S, Takeda I, Kitamura K, et al. Vanishing tumor of the abdomen in patient with Sjogren\u2019s syndrome. Dig Dis. 1978;23:75\u201379.","journal-title":"Dig Dis"},{"key":"5746_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0046-8177(91)90087-6","volume":"22","author":"K Kawaguchi","year":"1991","unstructured":"Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387\u2013395.","journal-title":"Hum Pathol"},{"key":"5746_CR8","first-page":"640","volume":"24","author":"F Toki","year":"1992","unstructured":"Toki F, Kozu T, Oi I, et al. An unusual type of chronic pancreatitis showing \u201cdiffuse irregular narrowing of the entire main pancreatic duct\u201d on ERCP\u2014a report of four cases. Endoscopy. 1992;24:640. (abstract).","journal-title":"Endoscopy"},{"key":"5746_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"1995","unstructured":"Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med. 1995;344:732\u2013738.","journal-title":"New Engl J Med"},{"key":"5746_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(02)08359-9","volume":"359","author":"H Hamano","year":"2002","unstructured":"Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403\u20131404.","journal-title":"Lancet"},{"key":"5746_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982\u2013984.","journal-title":"J Gastroenterol"},{"key":"5746_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00535-006-1862-6","volume":"41","author":"T Kamisawa","year":"2006","unstructured":"Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613\u2013625.","journal-title":"J Gastroenterol"},{"key":"5746_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/s10165-006-0518-Y","volume":"16","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz\u2019s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335\u2013340.","journal-title":"Mod Rheumatol"},{"key":"5746_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/ard.2008.089169","volume":"68","author":"Y Masaki","year":"2009","unstructured":"Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310\u20131315.","journal-title":"Ann Rheum Dis"},{"key":"5746_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"5746_CR16","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061\u20133067.","journal-title":"Arthritis Rheum"},{"key":"5746_CR17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/00000478-200308000-00009","volume":"27","author":"K Notohara","year":"2003","unstructured":"Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119\u20131127.","journal-title":"Am J Surg Pathol"},{"key":"5746_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00428-004-1140-z","volume":"445","author":"G Zamboni","year":"2004","unstructured":"Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552\u2013563.","journal-title":"Virchows Arch"},{"key":"5746_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","volume":"139","author":"RP Sah","year":"2010","unstructured":"Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140\u2013148.","journal-title":"Gastroenterology"},{"key":"5746_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00535-011-0386-x","volume":"46","author":"K Okazaki","year":"2011","unstructured":"Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol. 2011;46:277\u2013288.","journal-title":"J Gastroenterol"},{"key":"5746_CR21","first-page":"585","volume":"17","author":"Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society","year":"2002","unstructured":"Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society [in Japanese]. J Jpn Pancreas Soc. 2002;17:585\u2013587.","journal-title":"J Jpn Pancreas Soc"},{"key":"5746_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00535-006-1868-0","volume":"41","author":"K Okazaki","year":"2006","unstructured":"Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626\u2013631.","journal-title":"J Gastroenterol"},{"key":"5746_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/MPA.0b013e3182706ed5","volume":"41","author":"T Shimosegawa","year":"2012","unstructured":"Shimosegawa T, Working Group Members of the Japan Pancreas Society; Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for\u00a0autoimmune\u00a0pancreatitis. Pancreas. 2012;41:1341\u20131342.","journal-title":"Pancreas"},{"key":"5746_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00535-014-0942-2","volume":"49","author":"K Okazaki","year":"2014","unstructured":"Okazaki K, Kawa S, Kamisawa T, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:567\u2013588.","journal-title":"J Gastroenterol"},{"key":"5746_CR25","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","volume":"4","author":"ST Chari","year":"2006","unstructured":"Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010\u20131016.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5746_CR26","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.3748\/wjg.v12.i16.2487","volume":"12","author":"KP Kim","year":"2006","unstructured":"Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12:2487\u20132496.","journal-title":"World J Gastroenterol"},{"key":"5746_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00535-008-2205-6","volume":"43","author":"M Otsuki","year":"2008","unstructured":"Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan\u2013Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403\u2013408.","journal-title":"J Gastroenterol"},{"key":"5746_CR28","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1038\/ajg.2009.327","volume":"104","author":"L Frulloni","year":"2009","unstructured":"Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288\u20132294.","journal-title":"Am J Gastroenterol"},{"key":"5746_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00108-008-2262-1","volume":"50","author":"A Schneider","year":"2009","unstructured":"Schneider A, L\u00f6hr JM. Autoimmune pancreatitis [in German]. Internist (Berl). 2009;50:318\u2013330.","journal-title":"Internist (Berl)"},{"key":"5746_CR30","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3899\/jrheum.091153","volume":"37","author":"Y Masaki","year":"2010","unstructured":"Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz\u2019s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol. 2010;37:1380\u20131385.","journal-title":"J Rheumatol"},{"key":"5746_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","volume":"19","author":"H Ohara","year":"2012","unstructured":"Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of\u00a0IgG4-related\u00a0sclerosing cholangitis\u00a02012. J Hepatobiliary Pancreat Sci. 2012;19:536\u2013542.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"5746_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","volume":"15","author":"M Kawano","year":"2010","unstructured":"Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2010;15:615\u2013626.","journal-title":"Clin Exp Nephrol"},{"key":"5746_CR33","doi-asserted-by":"publisher","first-page":"357071","DOI":"10.1155\/2012\/357071","volume":"2012","author":"K Okazaki","year":"2012","unstructured":"Okazaki K, Umehara H. Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol. 2012;2012:357071.","journal-title":"Int J Rheumatol"},{"key":"5746_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u20131192.","journal-title":"Mod Pathol"},{"key":"5746_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","volume":"17","author":"K Okazaki","year":"2017","unstructured":"Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17:1\u20136.","journal-title":"Pancreatology"},{"key":"5746_CR36","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u20131615.","journal-title":"Gut"},{"key":"5746_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pan.2016.03.017","volume":"16","author":"Y Bi","year":"2016","unstructured":"Bi Y, Hart PA, Law R, et al. Obstructive jaundice\u00a0in\u00a0autoimmune\u00a0pancreatitis\u00a0can be safely treated with corticosteroids alone without biliary stenting. Pancreatology. 2016;16:391\u2013396.","journal-title":"Pancreatology"},{"key":"5746_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","volume":"66","author":"A Masamune","year":"2017","unstructured":"Masamune A, Nishimori I, Kikuta K, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487\u2013494.","journal-title":"Gut"},{"key":"5746_CR39","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid therapy for autoimmune pancreatitis. Gut. 2009;58:1504\u20131507.","journal-title":"Gut"},{"key":"5746_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00535-007-2043-y","volume":"42","author":"I Nishimori","year":"2007","unstructured":"Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey. J Gastroenterol. 2007;42:6\u20138.","journal-title":"J Gastroenterol"},{"key":"5746_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00535-007-2051-y","volume":"42","author":"T Ito","year":"2007","unstructured":"Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;42:50\u201358.","journal-title":"J Gastroenterol"},{"key":"5746_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.mpa.0000188308.75043.e4","volume":"32","author":"T Muraki","year":"2006","unstructured":"Muraki T, Hamano H, Ochi Y, et al. Autoimmune\u00a0pancreatitis\u00a0and complement activation system. Pancreas. 2006;32:16\u201321.","journal-title":"Pancreas"},{"key":"5746_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00535-014-0945-z","volume":"49","author":"T Kamisawa","year":"2014","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961\u2013970.","journal-title":"J Gastroenterol"},{"key":"5746_CR44","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al. Second international symposium on IgG4-related disease. International consensus guidance statement on the management and treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67:688\u2013699.","journal-title":"Arthritis Rheumatol"},{"key":"5746_CR45","doi-asserted-by":"publisher","first-page":"10262","DOI":"10.1038\/s41598-018-28405-x","volume":"8","author":"M Shirakashi","year":"2018","unstructured":"Shirakashi M, Yoshifuji H, Kodama Y, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of\u00a0IgG4-related disease: a multicentre study. Sci Rep. 2018;8:10262. \n                    https:\/\/doi.org\/10.1038\/s41598-018-28405-x\n                    \n                  .","journal-title":"Sci Rep"},{"key":"5746_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2007.11.023","volume":"134","author":"DH Park","year":"2008","unstructured":"Park DH, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134:440\u2013446.","journal-title":"Gastroenterology"},{"key":"5746_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00535-014-0945-z","volume":"49","author":"T Kamisawa","year":"2014","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961\u2013970.","journal-title":"J Gastroenterol"},{"key":"5746_CR48","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1053\/j.gastro.2010.01.001","volume":"138","author":"SB Ko","year":"2010","unstructured":"Ko SB, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138:1988\u20131996.","journal-title":"Gastroenterology"},{"key":"5746_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MEG.0b013e3283431e23","volume":"23","author":"K Takuma","year":"2011","unstructured":"Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2011;23:146\u2013152.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5746_CR50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s00535-009-0049-3","volume":"44","author":"K Uchida","year":"2009","unstructured":"Uchida K, Yazumi S, Nishio A, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726\u2013732.","journal-title":"J Gastroenterol"},{"key":"5746_CR51","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1038\/ajg.2009.327","volume":"104","author":"L Frulloni","year":"2009","unstructured":"Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288\u20132294.","journal-title":"Am J Gastroenterol"},{"key":"5746_CR52","doi-asserted-by":"crossref","unstructured":"Maruyama M, Arakura N, Ozaki Y, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol. 2013;272595.","DOI":"10.1155\/2013\/272595"},{"key":"5746_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1750-1172-9-77","volume":"9","author":"M Maruyama","year":"2014","unstructured":"Maruyama M, Watanabe T, Kanai K, et al. Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis. 2014;9:77.","journal-title":"Orphanet J Rare Dis"},{"key":"5746_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pan.2014.04.029","volume":"14","author":"T Ikeura","year":"2014","unstructured":"Ikeura T, Miyoshi H, Uchida K, et al. Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Pancreatology. 2014;14:373\u2013379.","journal-title":"Pancreatology"},{"key":"5746_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2169\/internalmedicine.53.1342","volume":"53","author":"K Hirano","year":"2014","unstructured":"Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53:171\u2013176.","journal-title":"Intern Med"},{"key":"5746_CR56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ajg.2012.465","volume":"108","author":"M Shiokawa","year":"2013","unstructured":"Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013;108:610\u2013617.","journal-title":"Am J Gastroenterol"},{"key":"5746_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414\u2013418.","journal-title":"Mod Rheumatol"},{"key":"5746_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MPA.0b013e3181b65a1c","volume":"38","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Tsuruta K, Okamoto A, et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 2009;38:890\u2013895.","journal-title":"Pancreas"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05746-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05746-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05746-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:29:46Z","timestamp":1595978986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05746-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5746"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05746-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"30 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}